Arslanian reported decreased insulin sensitivity in fifteen obese adolescents with PCOS in whom metformin therapy (850 mg, twice daily) was associated with an improvement in glucose tolerance and a decrease in testosterone levels [191]. This evidence concerns the gene INS and polycystic ovary syndrome.